163 related articles for article (PubMed ID: 28558075)
1. A never-ending story: the steadily growing family of the FA and FA-like genes.
Gueiderikh A; Rosselli F; Neto JBC
Genet Mol Biol; 2017; 40(2):398-407. PubMed ID: 28558075
[TBL] [Abstract][Full Text] [Related]
2. DNA damage response and cancer therapeutics through the lens of the Fanconi Anemia DNA repair pathway.
Bhattacharjee S; Nandi S
Cell Commun Signal; 2017 Oct; 15(1):41. PubMed ID: 29017571
[TBL] [Abstract][Full Text] [Related]
3. Recent insights into the molecular basis of Fanconi anemia: genes, modifiers, and drivers.
Cheung RS; Taniguchi T
Int J Hematol; 2017 Sep; 106(3):335-344. PubMed ID: 28631178
[TBL] [Abstract][Full Text] [Related]
4. RFWD3-Mediated Ubiquitination Promotes Timely Removal of Both RPA and RAD51 from DNA Damage Sites to Facilitate Homologous Recombination.
Inano S; Sato K; Katsuki Y; Kobayashi W; Tanaka H; Nakajima K; Nakada S; Miyoshi H; Knies K; Takaori-Kondo A; Schindler D; Ishiai M; Kurumizaka H; Takata M
Mol Cell; 2017 Jun; 66(5):622-634.e8. PubMed ID: 28575658
[TBL] [Abstract][Full Text] [Related]
5. RPA-Mediated Recruitment of the E3 Ligase RFWD3 Is Vital for Interstrand Crosslink Repair and Human Health.
Feeney L; Muñoz IM; Lachaud C; Toth R; Appleton PL; Schindler D; Rouse J
Mol Cell; 2017 Jun; 66(5):610-621.e4. PubMed ID: 28575657
[TBL] [Abstract][Full Text] [Related]
6. RPA activates the XPF-ERCC1 endonuclease to initiate processing of DNA interstrand crosslinks.
Abdullah UB; McGouran JF; Brolih S; Ptchelkine D; El-Sagheer AH; Brown T; McHugh PJ
EMBO J; 2017 Jul; 36(14):2047-2060. PubMed ID: 28607004
[TBL] [Abstract][Full Text] [Related]
7. Biallelic mutations in the ubiquitin ligase RFWD3 cause Fanconi anemia.
Knies K; Inano S; Ramírez MJ; Ishiai M; Surrallés J; Takata M; Schindler D
J Clin Invest; 2017 Aug; 127(8):3013-3027. PubMed ID: 28691929
[TBL] [Abstract][Full Text] [Related]
8. Biallelic truncating FANCM mutations cause early-onset cancer but not Fanconi anemia.
Bogliolo M; Bluteau D; Lespinasse J; Pujol R; Vasquez N; d'Enghien CD; Stoppa-Lyonnet D; Leblanc T; Soulier J; Surrallés J
Genet Med; 2018 Apr; 20(4):458-463. PubMed ID: 28837157
[TBL] [Abstract][Full Text] [Related]
9. Emerging functions of the Fanconi anemia pathway at a glance.
Sumpter R; Levine B
J Cell Sci; 2017 Aug; 130(16):2657-2662. PubMed ID: 28811338
[TBL] [Abstract][Full Text] [Related]
10. Ubiquitination-Linked Phosphorylation of the FANCI S/TQ Cluster Contributes to Activation of the Fanconi Anemia I/D2 Complex.
Cheung RS; Castella M; Abeyta A; Gafken PR; Tucker N; Taniguchi T
Cell Rep; 2017 Jun; 19(12):2432-2440. PubMed ID: 28636932
[TBL] [Abstract][Full Text] [Related]
11. Structural and functional relationships of FAN1.
Jin H; Cho Y
DNA Repair (Amst); 2017 Aug; 56():135-143. PubMed ID: 28623094
[TBL] [Abstract][Full Text] [Related]
12. Individuals with FANCM biallelic mutations do not develop Fanconi anemia, but show risk for breast cancer, chemotherapy toxicity and may display chromosome fragility.
Catucci I; Osorio A; Arver B; Neidhardt G; Bogliolo M; Zanardi F; Riboni M; Minardi S; Pujol R; Azzollini J; Peissel B; Manoukian S; De Vecchi G; Casola S; Hauke J; Richters L; Rhiem K; Schmutzler RK; Wallander K; Törngren T; Borg Å; Radice P; Surrallés J; Hahnen E; Ehrencrona H; Kvist A; Benitez J; Peterlongo P
Genet Med; 2018 Apr; 20(4):452-457. PubMed ID: 28837162
[TBL] [Abstract][Full Text] [Related]
13. Chronic treatment with cisplatin induces chemoresistance through the TIP60-mediated Fanconi anemia and homologous recombination repair pathways.
Su WP; Ho YC; Wu CK; Hsu SH; Shiu JL; Huang JC; Chang SB; Chiu WT; Hung JJ; Liu TL; Wu WS; Wu PY; Su WC; Chang JY; Liaw H
Sci Rep; 2017 Jun; 7(1):3879. PubMed ID: 28634400
[TBL] [Abstract][Full Text] [Related]
14. Recommendations for Childhood Cancer Screening and Surveillance in DNA Repair Disorders.
Walsh MF; Chang VY; Kohlmann WK; Scott HS; Cunniff C; Bourdeaut F; Molenaar JJ; Porter CC; Sandlund JT; Plon SE; Wang LL; Savage SA
Clin Cancer Res; 2017 Jun; 23(11):e23-e31. PubMed ID: 28572264
[TBL] [Abstract][Full Text] [Related]
15. FANCA deficiency promotes leukaemic progression by allowing the emergence of cells carrying oncogenic driver mutations.
Pawlikowska P; Delestré L; Gregoricchio S; Oppezzo A; Esposito M; Diop MB; Rosselli F; Guillouf C
Oncogene; 2023 Sep; 42(37):2764-2775. PubMed ID: 37573408
[TBL] [Abstract][Full Text] [Related]
16. Fanca deficiency is associated with alterations in osteoclastogenesis that are rescued by TNFα.
Oppezzo A; Monney L; Kilian H; Slimani L; Maczkowiak-Chartois F; Rosselli F
Cell Biosci; 2023 Jun; 13(1):115. PubMed ID: 37355617
[TBL] [Abstract][Full Text] [Related]
17. Mutations in AcrR and RNA Polymerase Confer High-Level Resistance to Psoralen-UVA Irradiation.
Worley TK; Weber EA; Acott JD; Shimpi RS; Cole JM; Courcelle CT; Courcelle J
J Bacteriol; 2023 Jun; 205(6):e0012623. PubMed ID: 37249472
[TBL] [Abstract][Full Text] [Related]
18. Safeguarding DNA Replication: A Golden Touch of MiDAS and Other Mechanisms.
Al Ahmad Nachar B; Rosselli F
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232633
[TBL] [Abstract][Full Text] [Related]
19. Polyclonal evolution of Fanconi anemia to MDS and AML revealed at single cell resolution.
Chang L; Cui Z; Shi D; Chu Y; Wang B; Wan Y; Ma Q; Zhang R; Li H; Cheng X; Cheng T; Zhu X; Li C; Yuan W
Exp Hematol Oncol; 2022 Sep; 11(1):64. PubMed ID: 36167633
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
